Correlation Between Chung Hwa and Li Kang

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chung Hwa and Li Kang at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chung Hwa and Li Kang into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chung Hwa Chemical and Li Kang Biomedical, you can compare the effects of market volatilities on Chung Hwa and Li Kang and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chung Hwa with a short position of Li Kang. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chung Hwa and Li Kang.

Diversification Opportunities for Chung Hwa and Li Kang

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Chung and 6242 is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Chung Hwa Chemical and Li Kang Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Li Kang Biomedical and Chung Hwa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chung Hwa Chemical are associated (or correlated) with Li Kang. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Li Kang Biomedical has no effect on the direction of Chung Hwa i.e., Chung Hwa and Li Kang go up and down completely randomly.

Pair Corralation between Chung Hwa and Li Kang

Assuming the 90 days trading horizon Chung Hwa Chemical is expected to under-perform the Li Kang. In addition to that, Chung Hwa is 3.65 times more volatile than Li Kang Biomedical. It trades about -0.06 of its total potential returns per unit of risk. Li Kang Biomedical is currently generating about -0.01 per unit of volatility. If you would invest  4,320  in Li Kang Biomedical on September 13, 2024 and sell it today you would lose (30.00) from holding Li Kang Biomedical or give up 0.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Chung Hwa Chemical  vs.  Li Kang Biomedical

 Performance 
       Timeline  
Chung Hwa Chemical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chung Hwa Chemical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Li Kang Biomedical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Li Kang Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Li Kang is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Chung Hwa and Li Kang Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chung Hwa and Li Kang

The main advantage of trading using opposite Chung Hwa and Li Kang positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chung Hwa position performs unexpectedly, Li Kang can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Li Kang will offset losses from the drop in Li Kang's long position.
The idea behind Chung Hwa Chemical and Li Kang Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk